When High Risk Patients Need Specialty Care during COVID-19
More Accredo patients are refilling prescriptions by app and online in the face of COVID-19, while still receiving customized clinical care. (Estimated reading time: ~2 mins.)
Patients with inflammatory conditions and multiple sclerosis can overcome barriers to taking their medications with the help of financial assistance programs.
The Express Scripts Office of Clinical Evaluation and Policy lists the drugs that were approved by the Food and Drug Administration (FDA) in June 2020. (Estimated Reading Time: ~10 mins.)
Nonadherence Puts Patients With Multiple Sclerosis on a Dangerous Path
Patients diagnosed with multiple sclerosis (MS) face unpredictable and increasingly debilitating symptoms. Nonadherence can make these adverse events more costly and dangerous.
Accredo helps patients manage the unique complexities of a rare disease with best-in-class clinical care while supporting payers with appropriate management strategies.
Health Care Trend: Managing Rising Prescription Drug Costs
Ensuring access and affordability in the face of increasing drug costs and market pressures continues to be a priority for plan sponsors. (Estimated reading time: ~3 mins.)
Getting to the Rare Diagnosis: 7.6 Years and 7 Different Doctors
For patients with rare disease, getting to the right diagnosis is just the beginning of their journey. Our Rare Conditions Care Value Program® offers personalized support to help patients manage their...
2019 National Preferred Formulary: Better Access. Better Value.
Our National Preferred Formulary will provide payers and their members access to 3,886 medications while saving $3.2 billion on their prescription drug bill.
